SurvivorNet
@SurvivorNetTeam
The trusted source for information on cancer built in collaboration with millions of patients and the country's leading academic medical centers.
Slimming safely: today's #SNNewsletter covers what you need to know about GLP-1 drugs. • GLP-1 medications & thyroid cancer risk • Tackling mental health during a thyroid cancer diagnosis Read about that and more below.
This is worth listening to you. When extremely respected, independent, thinking researchers believe that the data just Justify an approval…. People in myeloma should take notice.
Recently, ODAC voted "NO" on approving Blenrep 4 R/R Myeloma. In a back-to-back #HUExpress, I get @VincentRK thoughts on that decision and I also host @GregNowakowski to give us "behind the scenes" on what happened that day at ODAC. Two must watch EPs coming your way this week.
This is one of the really great and profound questions for oncology. Why do some people respond better to checkpoint inhibitors? And why do they ultimately stop working? Now if this is got the data to back it up what do we do about it? @fredhutch
A landmark study published in @Nature by @aaronmring et al. has revealed that autoantibodies — immune proteins traditionally associated with autoimmune disease — may profoundly influence how cancer patients respond to immunotherapy. bit.ly/4o4HANS
Congratulations to @DrMDavids who was awarded the 2025 @CllSociety Clinical Scholar Award for his work: Optimizing Glofitamab Combination Therapy in Richter’s Transformation. Read more: bit.ly/4eZLQtP
There is comfort level to be gained. Thank you for this.
You need some data as to how to use dato? Below guide offers a practical way to use Datroway in your clinic! ☑️mucositis ☑️pneumonitis ☑️ocular tox Now that Dato-dxd is approved for both breast and EGFR-mutated NSCLC indications, implementation of best practices is key! 👀…
Important: Belantamab (Blenrep) approved in Canada and Europe for relapsed myeloma. Belantamab is an important addition to the treatments we have. Despite the negative ODAC vote and concerns about dosing and corneal toxicity, I hope it is approved in the US as well.
A visionary $100 million matching grant from the Weill Family Foundation is bringing together @StanfordCancer and @UCSF to launch the Weill Cancer Hub West -- an innovative collaboration that will transform cancer research and care in the next decade. stan.md/4f2tRD7
The role of philanthropy to fill the gap in funding for basic research is going to immediately become hugely more important-/ it will be even more important to make better bets with less funding around. There are different philosophies on how to do this, one says bet on people…
Backed by a $100M gift from Joan and Sandy Weill, UCSF and @StanfordMed @StanfordCancer are launching Weill Cancer Hub West, a $200M initiative in team science to accelerate cancer research and improve care over the next decade. tiny.ucsf.edu/ppVRqt
It’s just a huge deal to offer an option to treat this disease so much earlier
A historic day for myeloma!! After 5 decades of research. European Commission / EMA approves Daratumumab as the first ever approved treatment for high risk smoldering myeloma based on the results of the AQUILA trial. @thanosdimop @PlasmaCellPete globenewswire.com/news-release/2…
What is the treatment path for glioma patients? Dr. Henry Friedman of @DukeCancer breaks it down: • Diagnosis • Surgery • Molecular Testing & Targeted Therapy • Chemotherapy & Radiation Therapy • Clinical Trials Each step plays a critical role. Read more below.
Considering a clinical trial as part your treatment plan? “The best care for patients [can be] within the confines of a clinical trial” says @MoffittNews oncologist Dr. Michael Jain. Learn what questions to ask and understand the process of enrolling in a clinical trial:
Here's what you should know about motherhood after cancer. Infertility can be a side effect of certain treatments—but fertility preservation before cancer treatment can double your chances of giving birth afterwards. Talk to your doctor about your options today.
What is next generation sequencing (NGS) and how does it apply to your treatment journey? Dr. Valsamo Anagnastou from @hopkinskimmel walks through the ABCs of NGS in our digital guide. Explore here:
Today’s #SNNewsletter shares stories of resilience in every chapter. • Judy Blume, two-time cancer survivor, on her Netflix hit Forever • WWII vet and great-grandfather to 19 shares his skin cancer fight • How Adam Whitt found healing in golf after leukemia Read more below.
Ritu Salani from @UCLAHealth discusses new technologies that can help prevent ovarian cancer. Genetic testing, surveillance, and medications now play crucial roles in understanding cancer susceptibility, detecting it early, and reducing risk. Learn what steps you can take.
Feeling overwhelmed during thyroid cancer treatment? @UMRogelCancer’s Dr. Megan Haymart says: “Worry is natural … peers like you also are worried about their cancer.” You’re not alone. Find resources that can help below.
What are the symptoms of an Acute Myeloid Leukemia (AML) relapse? @KUMedCenter’s Dr. Tara Lin shares what to watch for: • Fatigue & shortness of breath • Bruising • Anemia • Infections Early detection = better outcomes. Read more below.
Today’s #SNNewsletter is a powerful reminder that hope starts from within. • How a mom of 2 & real estate agent beat stage 4 cancer • NFL's Jim Kelly on the “Four F’s” during his 3 cancer battles • Optune Gio: a new treatment device for lung & brain cancer Read more below.
Not enough people know how truly excellent the oncologist are @RoswellPark — there’s an incredible legacy but every day we hear from patients who are being helped. World class// keep doing what you do.
📣 Roswell Park is growing! We’re proud to welcome eight exceptional new faculty members across seven departments — bringing deep expertise in surgical and medical oncology, dermatology, pathology, anesthesiology, and more. Meet the team here: roswellpark.org/newsroom/20250…
Endometriosis Vs. Endometrial Cancer — What’s the Difference? Dr. Bobbie Rimel of @CSCancerCenter explains: • Endometriosis: benign cells outside the uterus • Endometrial cancer: malignant cells inside the uterus Having one doesn’t mean you’ll get the other. Learn the signs.